These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 937064)

  • 1. Chemical composition and rate of passage across semipermeable membranes of basic peptides isolated from peritoneal dialysis fluid from patients with chronic renal failure.
    Lutz W
    Acta Med Pol; 1976; 17(2):137-47. PubMed ID: 937064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of peritoneal dialysis using dialysis fluid of modernized composition].
    Janicka L; Ksiazek A; Solski J; Majdan M; Bocheńska-Nowacka E; Bednarek-Skublewska A; Spasiewicz D
    Wiad Lek; 1990 Jun; 43(12):564-71. PubMed ID: 2260311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Composition of amino acid in blood and dialysate by patients with in chronic renal insufficiency by peritoneal dialysis].
    Pichugina IS; Gapparov MM; Chukarina EV; Vetchinnikova ON; Vatazin AV
    Vopr Pitan; 2008; 77(3):45-8. PubMed ID: 18669331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How peritoneal dialysis works.
    Kelley KT
    Nephrol Nurs J; 2004; 31(5):481-2, 488-9; quiz 490-1. PubMed ID: 15518250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transport processes--ultrafiltration in peritoneal dialysis].
    Nesić V; Dimitrijević Z; Stojimirović B
    Srp Arh Celok Lek; 1996; 124 Suppl 1():159-62. PubMed ID: 9102889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of strongly basic uremic peptide on liberation of lipoprotein lipase activity from human adipose cells.
    Lutz W
    Acta Med Pol; 1976; 17(1):55-70. PubMed ID: 1258692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].
    Kuźniak J; Grzegorzewska A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):123-5. PubMed ID: 1437798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peritoneal dialysis].
    Lepaul A; Maurice D; Haentjens B
    Rev Infirm; 2002 Oct; (84):40-2. PubMed ID: 12432641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of peritoneal dialysis in the treatment of terminal chronic renal insufficiency. Survival of patients and method].
    Ryckelynck JP; Hurault de Ligny B; Levaltier B; Cardineau E; Le Goff C; Batho JM
    Nephrologie; 1995; 16(1):85-92. PubMed ID: 7700425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
    Grzegorzewska A; Antoniewicz K; Kuźniak J; Zawadzka E
    Przegl Lek; 1990; 47(10):686-90. PubMed ID: 2089444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis in renal failure associated with spinal cord injury.
    Vaziri ND; Lopez G; Nikakhtar B; Gordon S; Penera N
    J Am Paraplegia Soc; 1984 Oct; 7(4):63-5. PubMed ID: 6512526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal exchange volume and dialysate flow rate in peritoneal dialysis. A clinical study.
    Kalra OP; Abrol L; Chopra JS; Agarwal SK; Prakash C
    J Assoc Physicians India; 1989 Dec; 37(12):762-4. PubMed ID: 2699986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to preserve residual renal function in patients with chronic kidney disease and on dialysis?
    Krediet RT
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii42-6. PubMed ID: 16825260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regular use of peritoneal dialysis in chronic renal failure].
    Pintér J; Szporny G; Sallai Z; Hronszky I
    Orv Hetil; 1969 Oct; 110(43):2513-9. PubMed ID: 5358761
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of furosemide added to peritoneal dialysis fluid on hydroxyproline excretion in dialysate and urine].
    Sucharzewska-Tomczak M; Grzegorzewska A
    Przegl Lek; 1994; 51(7):300-2. PubMed ID: 7871203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimization of peritoneal dialysis using diffusion curves].
    Korten G
    Z Urol Nephrol; 1985 Feb; 78(2):111-5. PubMed ID: 3993241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peritoneal dialysis in the treatment of chronic kidney failure in children].
    Sergeeva TV
    Urol Nefrol (Mosk); 1981; (6):61-4. PubMed ID: 7032029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.